Literature DB >> 8019929

Breast cancer detection guidelines for women aged 40 to 49 years: rationale for the American Cancer Society reaffirmation of recommendations. American Cancer Society.

C Mettlin1, C R Smart.   

Abstract

Over the past year, the National Cancer Institute has altered its guidelines for early breast cancer screening by omitting any recommendation for mammography and clinical breast examination for women aged 40 to 49 years, while the American Cancer Society has reaffirmed its recommendation for these screening procedures in this age group. This article reviews the process and some of the evidence the American Cancer Society has relied upon in reaffirming its recommended guidelines for early breast cancer detection.

Entities:  

Mesh:

Year:  1994        PMID: 8019929     DOI: 10.3322/canjclin.44.4.248

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  4 in total

1.  Screening mammography and constructs from the transtheoretical model: Associations using two definitions of the stages-of-adoption.

Authors:  W Rakowski; B Ehrich; C E Dubé; D N Pearlman; M G Goldstein; K K Peterson; B K Rimer; H Woolverton
Journal:  Ann Behav Med       Date:  1996-06

Review 2.  Clinical practice guidelines in oncology: pros and cons.

Authors:  M Markman
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

3.  Women's responses to changes in U.S. Preventive Task Force's mammography screening guidelines: results of focus groups with ethnically diverse women.

Authors:  Jennifer D Allen; Shirley Morrison Bluethmann; Margaret Sheets; Kelly Morrison Opdyke; Kathryn Gates-Ferris; Marc Hurlbert; Elizabeth Harden
Journal:  BMC Public Health       Date:  2013-12-12       Impact factor: 3.295

4.  An exploration for quantification of overdiagnosis and its effect for breast cancer screening.

Authors:  Lei Yang; Shengfeng Wang; Yubei Huang
Journal:  Chin J Cancer Res       Date:  2020-02       Impact factor: 5.087

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.